How Long Do Microplastics Stay in Your Body? Unknown

What is the honest answer?

The honest answer is unknown. The most current direct review we found, published online on September 25, 2026, evaluates absorption, distribution, metabolism and excretion rather than inferring a timeline from detection. It concludes that no human mass-balance study has measured an absorption fraction, excretion pathways are poorly characterized and systemic-clearance kinetics are entirely unknown.

That distinction matters. A particle in stool shows an exit route. A polymer signal in blood or tissue shows internal exposure under that method. Neither observation tells researchers when the material entered, whether it remained in one compartment, whether it recirculated or how rapidly the body removed comparable particles.

Why stool does not prove a 24–72-hour microplastic timeline

The 2019 prospective case series found a median of 20 particles per 10 grams of stool in eight adults. It was an important demonstration of fecal exposure and excretion, but every participant supplied only one sample. The paper’s stated limitations say that the particles’ origin and fate in the gastrointestinal tract were not investigated.

A general food-transit estimate cannot be converted into a microplastic half-life. The study did not give participants a labeled particle dose and then recover that dose over time. It could not distinguish particles from recent food, older material moving at a different rate, swallowed airborne particles or contamination not captured by the study design. It also could not quantify the fraction that was never absorbed.

What blood and urine can—and cannot—tell us

Leslie and colleagues reported quantifiable plastic-polymer mass in 17 of 22 blood donors. That was a one-time sample, not a kinetic experiment. Red-blood-cell lifespan does not supply a particle half-life because the study did not establish that detected material was inside red blood cells, measure the same people over time or track a known dose.

A six-person preliminary urine study identified four fragments across four samples. It suggests that urinary elimination may occur for some material under that method, but it cannot tell us what proportion of a person’s exposure leaves through urine. Detection in an excretion sample is not the same as measuring total clearance.

Why tissue detection is not a residence-time clock

The 2024 carotid-atheroma study detected polyethylene in plaques from 150 of 257 patients who completed follow-up and reported an association with a composite cardiovascular outcome. It was observational and did not measure when a detected polymer entered the plaque. Plaque may develop over years, but the age of the plaque does not prove that every measured polymer signal has the same age.

The brain study was published in Nature Medicine in February 2025, not 2024. It compared postmortem samples from different decedents and found higher measured polymer concentrations in 2024 than in 2016 samples. The authors explicitly wrote that brain-clearance rates and elimination routes remain uncharacterized. They also found no correlation between measured brain plastic and age at death, which does not support a simple lifetime-accumulation timeline.

The brain measurements also have an active methods debate. A 2025 Matters Arising critique raised concerns about digestion, biological interference and quality control. In their reply, the study authors defended their combined evidence while acknowledging uncertainties in current nanoplastic-detection methods. A useful summary must carry both the finding and the dispute; neither side supplies a human half-life.

Why size and method make one timeline unlikely

“Microplastics” covers a broad range of polymers, shapes and sizes, while “nanoplastics” covers even smaller particles and does not have one universally applied measurement boundary. Larger particles may remain in the gut lumen; smaller particles may interact differently with biological barriers. But the 2026 ADME review finds that human uptake is still quantitatively undefined. It also notes that routine infrared and Raman methods have poorer sensitivity in the submicrometre range, while newer methods are not yet sufficiently validated for complex human samples.

Polymer backbones are generally resistant to ordinary enzymatic metabolism, but that fact alone does not prove permanent residence. Particles may be physically transported, fragmented, altered at the surface, redistributed or excreted. Researchers need to measure those processes rather than replace missing kinetics with the lifespan of an organ or tissue.

Has any detox method been shown to speed clearance?

No controlled human trial has shown that a supplement, diet, sauna, sweat protocol or medical procedure accelerates systemic microplastic clearance. A 2025 clearance-strategies review describes this as an undeveloped research area and discusses possible future biomedical approaches; it does not validate a consumer treatment.

Hydration and dietary fibre are reasonable general-health practices. They should not be presented as microplastic treatments or as proven ways to reduce particle absorption. Activated charcoal, bentonite, zeolite, milk thistle, NAC and glutathione have not been shown to clear polymer particles from human tissue. Apheresis and plasma exchange are medical procedures with specific indications, not evidence-based microplastic detox services.

The FDA’s current assessment says substantial analytical and health-effect gaps remain and that current evidence does not demonstrate that the levels found in foods pose a human-health risk. The WHO review likewise emphasizes major evidence limitations. These positions do not prove that every exposure is harmless; they set a boundary on what consumer advice can currently claim.

What would establish a real clearance timeline?

1. A known, ethically appropriate tracer. Researchers would need a distinguishable particle dose rather than background environmental exposure.
2. Repeated samples. Blood, stool and urine would need to be collected at defined intervals, with longer follow-up for tissue compartments.
3. Mass balance. The administered or inhaled amount, recovered amount and analytical losses would need to be reconciled.
4. Size-resolved methods. The same validated methods and contamination controls would need to cover both micro- and nanoplastic fractions.
5. Human kinetic modelling. A physiologically based toxicokinetic model would need validation against actual human tracer or biomonitoring data.

Until that evidence exists, “24 hours,” “months,” “years” and “forever” are not defensible general answers.

What can you reasonably do now?

If you want to reduce avoidable plastic contact without treating it as a detox, focus on choices that are easy to verify: follow food-contact instructions, avoid heating products that are not intended for heat, replace visibly damaged food-contact items, and control indoor dust with ordinary ventilation and cleaning. These steps reduce particular contact opportunities; they do not come with a proven percentage reduction in body burden.

For related evidence boundaries, read whether microplastic-removal supplements work, what the blood study measured, and what the plaque study can support.

Use the App

Review contact points without inventing a detox score

Use the scanner to identify disclosed materials and common heat, wear and food-contact questions. It cannot measure particles in your body or calculate a personal clearance time.